3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Sleep Initiation and Maintenance Disorders
8
Anxiety Disorders
6
Neoplasms
5
Fatigue
4
Lymphoma
3
Depression
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Nervous System Diseases
2
Lymphoma, Follicular
2
Glioma
2
Weight Loss
1
Weight Gain
1
Uterine Cervical Neoplasms
1
Tobacco Use Disorder
1
Substance-Related Disorders
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Ovarian Neoplasms
1
Oligodendroglioma
1
Neoplasm Metastasis
1
Myasthenia Gravis
1
Multiple Myeloma
1
Mental Disorders
1
Meningioma
1
Melanoma
1
Medication Adherence
1
Lung Neoplasms
1
Leukemia, Myeloid, Acute
1
Hepatitis B
1
Interventions
Temozolomide
100
Radiotherapy
49
Magnetic Resonance Spectroscopy
38
Radiation
28
Specimen Handling
25
pembrolizumab
22
Bevacizumab
22
Lomustine
16
Nivolumab
14
Surgical Procedures, Operative
10
atezolizumab
8
Cyclophosphamide
8
Biopsy
8
abemaciclib
7
Ipilimumab
7
fludarabine
6
Radiotherapy, Intensity-Modulated
6
Carboplatin
6
Aminolevulinic Acid
6
olaparib
5
Metformin
5
Drug Therapy
5
Diet, Ketogenic
5
Dianhydrogalactitol
5
poly ICLC
4
cemiplimab
4
Radiosurgery
4
Photons
4
Leukapheresis
4
Immunoglobulin G
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Glioblastoma
×
Cognitive Behavioral Therapy
×
1 year
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled